Skip to content

Derrell Porter, Director at Acumen Pharmaceuticals, sold ABOS on Jun 16, 2026

Data as of Oct 27

▼ SELL$29.8K12,800 shares at $2.33Derrell Porter DirectorABOS Acumen Pharmaceuticals, Inc.
Watch ABOS
Traded
Jun 16, 2026
Disclosed
Jun 17, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Derrell Porter, Director at Acumen Pharmaceuticals, sold ABOS on Jun 16, 2026TRADEDDISCLOSED
ABOSSimilar stocks (XLV — its sector index fund), rebased to ABOS's price on the disclosure day
ABOS since disclosure
+0.4%
after the sale
Similar stocks (XLV) since disclosure
+18.9%
XLV — its sector index fund

Change in closing price from Jun 17, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLDerrell Porter DirectorABOS Acumen Pharmaceuticals, Inc.$30.3Kdisclosed Jun 17 · filed the same day
  2. ▼ SELLDerrell Porter DirectorABOS Acumen Pharmaceuticals, Inc.$15.1Kdisclosed Jun 17 · filed 2 days after the trade

See every trade on ABOS →